The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction-Reference-Cited by-同舟云学术

The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

Published:2017-07-11 Issue:1 Volume:16 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Wang Mei-Tzu,Lin Sheng-Che,Tang Pei-Ling,Hung Wang-Ting,Cheng Chin-Chang,Yang Jin-Shiou,Chang Hong-Tai,Liu Chun-Peng,Mar Guang-Yuan,Huang Wei-Chun^ORCID

Funder

Ministry of Science and Technology, Taiwan

Kaohsiung Veterans General Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-017-0572-0.pdf

Reference43 articles.

1. Fadini GP, Albiero M, Avogaro A. Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence. Vasc Pharmacol. 2015;73:1–3.

2. Chinda K, Palee S, Surinkaew S, Phornphutkul M, Chattipakorn S, Chattipakorn N. Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia–reperfusion injury. Int J Cardiol. 2013;167(2):451–7.

3. Kubota A, Takano H, Wang H, Hasegawa H, Tadokoro H, Hirose M, Kobara Y, Yamada-Inagawa T, Komuro I, Kobayashi Y. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction. J Mol Cell Cardiol. 2016;91:72–80.

4. Ervinna N, Mita T, Yasunari E, Azuma K, Tanaka R, Fujimura S, Sukmawati D, Nomiyama T, Kanazawa A, Kawamori R, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013;154(3):1260–70.

5. Ta NN, Schuyler CA, Li Y, Lopes-Virella MF, Huang Y. DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2011;58(2):157–66.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of Health-Related Quality of Life in Outpatients with Myocardial Infarction;Journal of Multidisciplinary Healthcare;2024-05

2. Cardioprotective effects of sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase 4 inhibitor in type 2 diabetes: A meta-analysis of comparative safety and efficacy;SAGE Open Medicine;2024-01

3. Recent advances in the diagnosis and management of acute myocardial infarction;Journal of the Chinese Medical Association;2023-10-06

4. Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus;Cardiovascular Diabetology;2023-07-22

5. Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study;Physiological Reports;2023-06